
Will Prevagen’s Deceptive Advertising Ever End?
Eight years after TINA.org alerted regulators, supplement ads continue to convey deceptive and misleading memory improvement claims.
In January 2013, another class-action lawsuit was filed against Pfizer regarding its marketing of Zoloft. This time, the allegation is that the drug label and marketing materials do not mention the numerous clinical trials in which Zoloft was shown to be no more effective in treating depression than placebo. Instead, Pfizer’s consumers are given the impression that Zoloft is very effective for treating depression. (Plumlee v. Pfizer, Inc., Case No. 13-cv-00414, N.D. Cal.)
Eight years after TINA.org alerted regulators, supplement ads continue to convey deceptive and misleading memory improvement claims.
Crypto trading MLM’s “aggressive earnings claims” are referred to regulators.
Deceptive mailer targets Medicare recipients.
Lawsuits allege some hard truths.
Brianna Atkinson, The Herald Sun